Fonte: Molecular Pharmaceutics. Unidades: IF, ICB, FM
Assuntos: BIOFÍSICA, FÍSICO-QUÍMICA, NANOPARTÍCULAS, SILICATOS, NEOPLASIAS MAMÁRIAS, FARMACOLOGIA EXPERIMENTAL, QUIMIOTERAPIA, ANTINEOPLÁSICOS, FARMACOLOGIA
ABNT
SALATA, Giovanna Cassone et al. Microemulsion for prolonged release of fenretinide in the mammary tissue and prevention of breast cancer development. Molecular Pharmaceutics, v. 18, n. 9, p. 3401-3417, 2021Tradução . . Disponível em: https://doi.org/10.1021/acs.molpharmaceut.1c00319. Acesso em: 31 out. 2024.APA
Salata, G. C., Malagó, I. D., Dartora, V. F. M. C., Pessoa, A. F. M., Fantini, M., Costa, S. K. P., et al. (2021). Microemulsion for prolonged release of fenretinide in the mammary tissue and prevention of breast cancer development. Molecular Pharmaceutics, 18( 9), 3401-3417. doi:10.1021/acs.molpharmaceut.1c00319NLM
Salata GC, Malagó ID, Dartora VFMC, Pessoa AFM, Fantini M, Costa SKP, Machado Neto JA, Lopes LB. Microemulsion for prolonged release of fenretinide in the mammary tissue and prevention of breast cancer development [Internet]. Molecular Pharmaceutics. 2021 ; 18( 9): 3401-3417.[citado 2024 out. 31 ] Available from: https://doi.org/10.1021/acs.molpharmaceut.1c00319Vancouver
Salata GC, Malagó ID, Dartora VFMC, Pessoa AFM, Fantini M, Costa SKP, Machado Neto JA, Lopes LB. Microemulsion for prolonged release of fenretinide in the mammary tissue and prevention of breast cancer development [Internet]. Molecular Pharmaceutics. 2021 ; 18( 9): 3401-3417.[citado 2024 out. 31 ] Available from: https://doi.org/10.1021/acs.molpharmaceut.1c00319